Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma
Open Access
- 1 January 2006
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (1), 109-111
- https://doi.org/10.1016/j.ejca.2005.08.034
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC)Journal of Clinical Pathology, 2006
- Irreversible pan-ErbB tyrosine kinase inhibitor CI-1033 induces caspase-independent apoptosis in colorectal cancer DiFi cell lineApoptosis, 2005
- Somatic Mutations of EGFR Gene in Squamous Cell Carcinoma of the Head and NeckClinical Cancer Research, 2005
- Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non–Small-Cell Lung Cancer: Current Knowledge and Future DirectionsJournal of Clinical Oncology, 2005
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLoS Medicine, 2005
- Absence ofEGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancerInternational Journal of Cancer, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Studies with ZD1839 in preclinical modelsSeminars in Oncology, 2003
- EGFR and cancer prognosisEuropean Journal Of Cancer, 2001